Form 4: Astera Labs Director Sells Shares Under Pre-Arranged 10b5-1 Plan

Astera Labs Director Manuel Alba sold 13,259 shares of common stock for $111 per share, executed automatically under a pre-arranged 10b5-1 trading plan.

Summary

• Manuel Alba, a Director of Astera Labs, Inc. (ALAB), reported a sale of common stock.
• On July 21, 2025, 13,259 shares of common stock were disposed of at a price of $111 per share.
• The transaction was executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Alba on May 31, 2024.
• Following the transaction, Mr. Alba directly owns 2,351 shares of common stock.
• Indirect beneficial ownership includes 1,874,498 shares via Alba Trust, 418,863 shares via Casa Alameda 2007, LLC, and 5,000 shares via spouse.
• Mr. Alba disclaims beneficial ownership of shares held by Alba Trust and Casa Alameda 2007, LLC, except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The transaction is a pre-scheduled sale under a 10b5-1 plan, which is a common practice for insiders to diversify holdings and manage liquidity without implying a negative outlook on the company's future prospects.

Positives

• The sale was conducted under a Rule 10b5-1 trading plan, indicating a pre-scheduled and routine transaction rather than a reaction to new negative company information.

Negatives

• The transaction represents an insider selling shares, which can sometimes be perceived negatively by the market, even if pre-planned.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may note the director's sale of shares, though it was pre-planned under a 10b5-1 trading plan and is generally considered a routine event.

Key Dates

Recommendation

The sale of shares by a director was executed under a pre-arranged 10b5-1 trading plan, which is a common and often routine practice for insiders to manage personal finances and diversify holdings. This type of transaction does not typically signal a change in the company's fundamental outlook or warrant a strong buy/sell recommendation, hence a 'hold' is appropriate as it's a neutral event.

Keywords

Astera Labs, ALAB, Form 4, insider trading, stock sale, 10b5-1 plan, director, beneficial ownership